openai ceo semaglutide experience OpenAI's Sam Altman Reveals He Was Hospitalized After Experimenting With a GLP-1 Drug OpenAI CEO Sam Altman said

Several GLP-1R agonists (GLP-1RA) have been approved to treat type 2 diabetes and have demonstrated benefits in managing obesity 16

Semaglutide and diarrhea often go hand-in-hand, but usually this is a sign your body is adjusting to the medication

GLP-1 receptor agonists come in different forms, including injectable formulations (Exenatide, Liraglutide, Dulaglutide, and Semaglutide) and oral formulations (Semaglutide)

When GLP-1 medications slow stomach emptying, patients experience changes in how and when bile is released into the digestive tract

Some experts suggest an induction-maintenance model : initiating treatment with subcutaneous injections for rapid initial weight loss, followed by long-term oral maintenance

One exception could be gallstone pancreatitis